<?xml version="1.0" encoding="UTF-8"?>
<p id="Par3">During a pandemic, there is no time to waste in the development and clinical testing of therapeutic modalities, including vaccines, nucleic acids, small molecules, convalescent serum, intravenous immunoglobulin G (IgG) and monoclonal antibodies (mAbs).</p>
